Clinical Trial Update: Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) [Phase 3]

View source ↗

Summary

Phase 3 trial update on long-term persistence of hepatitis B and pertussis antibody responses in healthy 4–5 year-old children previously vaccinated with Vaxeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Pertussis

Snippet

Sponsor: MCM Vaccines B.V. | Conditions: Hepatitis B, Pertussis | Phase 3 | Status: COMPLETED | Results posted: 2019-06-27